Avidity Biosciences, Inc. (RNA)
72.35
-0.02
(-0.03%)
USD |
NASDAQ |
Jan 12, 16:00
72.34
-0.02
(-0.02%)
After-Hours: 20:00
Avidity Biosciences Research and Development Expense (Quarterly): 154.95M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Novartis AG | 2.857B |
| Dyne Therapeutics, Inc. | 97.22M |
| EXACT Sciences Corp. | 117.22M |
| Astria Therapeutics, Inc. | 24.15M |
| Intellia Therapeutics, Inc. | 92.33M |